Proteomics

Dataset Information

0

Multiple myeloma-derived extracellular vesicles modulate the bone marrow immune microenvironment


ABSTRACT: One of the hallmarks of multiple myeloma (MM) is a permissive BM microenvironment. Increasing evidence suggest that cell-to-cell communication between myeloma and immune cells via tumor cell-derived extracellular vesicles (EV) plays a key role in the pathogenesis of MM. Hence, we aimed to explore BM immune alterations induced by MM-derived EV. For this, we inoculated immunocompetent BALB/cByJ mice with a myeloma cell line - MOPC315.BM -, inducing a MM phenotype. Upon tumor establishment, characterization of the BM microenvironment revealed the expression of both activation and suppressive markers by lymphocytes, such as Granzyme b and PD-1, respectively. In addition, conditioning of the animals with MOPC315.BM-derived EV, before transplantation of the MOPC315.BM tumor cells, did not anticipate the disease phenotype. However, it induced features of suppression in the BM milieu, such as an increase in PD-1 expression by CD4+ T cells. Overall, our findings reveal the involvement of MOPC315.BM-derived EV protein content as promoters of immune niche remodeling, strengthening the importance of assessing the mechanisms by which MM may impact the immune microenvironment.

INSTRUMENT(S): Q Exactive HF

ORGANISM(S): Mus Musculus (mouse)

TISSUE(S): Bone Marrow, Bone Marrow Cell

DISEASE(S): Multiple Myeloma

SUBMITTER: Rune Matthiesen  

LAB HEAD: Rune Matthiesen

PROVIDER: PXD032934 | Pride | 2022-07-05

REPOSITORIES: Pride

altmetric image

Publications

The Immune Microenvironment in Multiple Myeloma: Friend or Foe?

Lopes Raquel R   Caetano Joana J   Ferreira Bruna B   Barahona Filipa F   Carneiro Emilie Arnault EA   João Cristina C  

Cancers 20210205 4


Multiple myeloma (MM) is one of the most prevalent hematological cancers worldwide, characterized by the clonal expansion of neoplastic plasma cells in the bone marrow (BM). A combination of factors is implicated in disease progression, including BM immune microenvironment changes. Increasing evidence suggests that the disruption of immunological processes responsible for myeloma control ultimately leads to the escape from immune surveillance and resistance to immune effector function, resulting  ...[more]

Similar Datasets

2018-09-30 | GSE118282 | GEO
2013-07-24 | GSE39571 | GEO
2019-02-27 | PXD010600 | Pride
2013-07-24 | E-GEOD-39571 | biostudies-arrayexpress
2018-06-08 | GSE110271 | GEO
2018-06-08 | GSE110238 | GEO
2018-07-14 | GSE108915 | GEO
2021-04-14 | PXD019126 | Pride
2022-05-31 | PXD024121 | Pride
2014-11-23 | E-GEOD-46053 | biostudies-arrayexpress